In addition, expression of NRP1 is correlated with poor prognosis in various types of tumor, including lung cancer, colon cancer, ovarian cancer, and prostate cancer [8], implying that NRP1 could be a potential molecular target for treatments of tumor. Here, NRP1 is linked to neoplasm.